Suppr超能文献

支气管内活检在慢性阻塞性肺疾病和哮喘最终诊断中的应用:一项临床病理研究

Endobronchial biopsy in the final diagnosis of chronic obstructive pulmonary disease and asthma: a clinicopathological study.

作者信息

Arafah Maria Abdulrahim, Raddaoui Emad, Kassimi Faisal Al, Alhamad Esam H, Alboukai Ahmed Amer, Alshedoukhy Ahlam Abdullah, Ouban Abderrahman

机构信息

Dr. Maria Abdulrahman Arafah, Department of Pathology,, College of Medicine, King Saud University,, PO Box 2925, Riyadh 11461,, Saudi Arabia, M: +966555214611, marafah83@ gmail.com, ORCID: http://orcid. org/0000-0002-6847-5884.

出版信息

Ann Saudi Med. 2018 Mar-Apr;38(2):118-124. doi: 10.5144/0256-4947.2018.118.

Abstract

BACKGROUND

Asthma and chronic obstructive pulmonary disease (COPD) are chronic conditions with an increasing prevalence in developing countries. The evaluation of endobronchial biopsies has emerged as a tool to differentiate between both conditions via the measurement of the reticular basement membrane (RBM) thickness with various conclusions drawn from different studies.

OBJECTIVES

Compare the thickness of the RBM between asthma and COPD and evaluate other histomorphological features in both groups.

DESIGN

Prospective, descriptive and analytical.

SETTING

University teaching hospital.

PATIENTS AND METHODS

The study included patients with COPD and irreversible and reversible asthma with diagnosis based on clinical assessment, pulmonary function tests and high-resolution computed tomography scans. Endobronchial biopsies were obtained from all patients and, using a light microscope and a computerized image analyzer, the thickness of the reticular basement membrane was calculated in all patients. We also made a qualitative assessment of other histo-morphological features.

MAIN OUTCOME MEASURES

Mean RBM thickness.

SAMPLE SIZE

Thirty male patients.

RESULTS

The mean RBM thickness in asthmatic patients was 8.9 (2.4) micro m. The mean RBM thickness in COPD patients was 5.3 (1.1) micro m. However, there was no thickening of the RBM in patients with reversible asthma. The RBM was significantly thicker in patients with irreversible asthma than in patients with COPD or reversible asthma. There were no significant differences in epithelial desquamation or metaplasia, mucosal or submucosal inflammation, the presence of eosinophils, submucosal glandular hyperplasia or submucosal smooth muscle hyperplasia between groups.

CONCLUSIONS

The thickness of the RBM is the only reproducible histopathological feature to differentiate COPD from irreversible asthma.

LIMITATIONS

The study included a limited number of patients. A qualitative approach was used to compare epithelial cell injury, inflammation, submucosal glandular and muscular hyperplasia.

CONFLICT OF INTEREST

None.

摘要

背景

哮喘和慢性阻塞性肺疾病(COPD)是在发展中国家患病率不断上升的慢性疾病。支气管活检评估已成为一种通过测量网状基底膜(RBM)厚度来区分这两种疾病的工具,不同研究得出了各种结论。

目的

比较哮喘和COPD患者的RBM厚度,并评估两组的其他组织形态学特征。

设计

前瞻性、描述性和分析性研究。

地点

大学教学医院。

患者和方法

该研究纳入了COPD患者以及不可逆性和可逆性哮喘患者,诊断基于临床评估、肺功能测试和高分辨率计算机断层扫描。从所有患者获取支气管活检样本,使用光学显微镜和计算机图像分析仪计算所有患者的网状基底膜厚度。我们还对其他组织形态学特征进行了定性评估。

主要观察指标

RBM平均厚度。

样本量

30名男性患者。

结果

哮喘患者的RBM平均厚度为8.9(2.4)微米。COPD患者的RBM平均厚度为5.3(1.1)微米。然而,可逆性哮喘患者的RBM没有增厚。不可逆性哮喘患者的RBM明显厚于COPD患者或可逆性哮喘患者。两组之间在上皮脱落或化生、黏膜或黏膜下炎症、嗜酸性粒细胞的存在、黏膜下腺增生或黏膜下平滑肌增生方面没有显著差异。

结论

RBM厚度是区分COPD和不可逆性哮喘的唯一可重复的组织病理学特征。

局限性

该研究纳入的患者数量有限。采用定性方法比较上皮细胞损伤、炎症、黏膜下腺和肌肉增生。

利益冲突

无。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6071/6074367/b31ee7ca3918/asm-2-118f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验